Replies to post #60970 on SEASONALITY STOCK REPORTS

[Manti]

Thanks Ken. I also expect ALIM to do well soon:

[Manti]

After watching SAPX for a while, I've decided they are diluting. Factor that into the chart and it's a red flag.

ALIM is getting bought up. I'm betting it's a precursor to european approval of their treatment. If that approval comes it will do a DNDN.